...
首页> 外文期刊>Cell and Tissue Research >Improving therapeutic potential of GDNF family ligands
【24h】

Improving therapeutic potential of GDNF family ligands

机译:改善GDNF家族配体的治疗潜力

获取原文
获取原文并翻译 | 示例
           

摘要

The last decade has been a frustrating time for investigators who had envisioned major advances in the treatment of Parkinson's disease using neurotrophic factors. The first trials of glial cell line-derived neurotrophic factor for treating Parkinson's disease were very promising. Later blinded control trials were disappointing, not reaching the predetermined outcomes for improvement in motor function. Consideration of the problems in the studies as well as the biology of the neurotrophins used can potentially lead to more effective therapies. Parkinson's disease presents a multitude of opportunities for the cell biologist wanting to understand its pathology and to find possible new avenues for treatment.
机译:过去十年对那些曾设想使用神经营养因子治疗帕金森病取得重大进展的研究人员来说是一段令人沮丧的时期。胶质细胞源性神经营养因子治疗帕金森病的首次试验非常有希望。后来的盲对照试验令人失望,没有达到改善运动功能的预定结果。考虑到研究中的问题以及所用神经营养素的生物学特性,可能会产生更有效的治疗方法。帕金森病为细胞生物学家提供了许多机会,他们希望了解帕金森病的病理学,并找到可能的新治疗途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号